FIELD: medicine; pharmaceuticals.
SUBSTANCE: disclosed is a pharmaceutical composition for external use comprising S-flurbiprofen or a pharmaceutically acceptable salt thereof, mint oil and at least one component selected from a group consisting of an ester having two medium chain fatty acids bound to propylene glycol and an ester having three medium chain fatty acids bound with glycerol. Ester, having two medium chain fatty acids bound to propylene glycol, is propylene glycol dicaprylate. Ester having three medium chain fatty acids bound with glycerol is glyceryl tricaprate.
EFFECT: composition according to the invention provides stability of S-flurbiprofen during storage.
9 cl, 4 dwg, 4 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION, CONTAINING BICYCLIC COMPOUND, AND METHOD OF BICYCLIC COMPOUND STABILISATION | 2007 |
|
RU2440144C2 |
| READY-TO-USE DOSAGE FORMS FOR INJECTION | 2020 |
|
RU2777360C1 |
| OPHTHALMIC COMPOSITION | 2012 |
|
RU2639472C2 |
| ANTIPARASITIC COMPOSITIONS TO BE USED BY POURING | 2018 |
|
RU2802299C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING LULICONAZOLE | 2013 |
|
RU2621615C2 |
| SPRAYABLE TOPICAL CARRIER AND COMPOSITION CONTAINING PHOSPHATIDYLCHOLINE | 2014 |
|
RU2699651C1 |
| PHARMACEUTICAL COMPOSITIONS AND METHOD OF TREATING INFLAMMATORY IN CATTLE AND OTHER ANIMALS | 2007 |
|
RU2466715C2 |
| ARYLSULPHONAMIDE-SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS | 2005 |
|
RU2406721C2 |
| PHARMACEUTICAL COMPOSITIONS OF THERAPEUTIC, ANTI-INFLAMMATORY AND ANALGETIC AGENT FOR TOPICAL APPLICATION AND METHOD OF THEIR PREPARING | 1996 |
|
RU2157689C2 |
| PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2639482C2 |
